New imaging study aims to uncover hidden inflammation in genetic heart disease
NCT ID NCT05450783
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is looking at 80 people with a genetic heart condition called arrhythmogenic cardiomyopathy, which can cause sudden cardiac death. Researchers will use a special PET-MRI scan to see if there is inflammation in the heart muscle, which is hard to detect with standard tests. The goal is to better understand how inflammation affects the disease and its outcomes, without offering any direct treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a non-invasive way to detect inflammation in the heart, helping doctors better predict disease progression and guide future treatments.
- What could go wrong
- This is an early observational study with only 80 participants, so results may not apply to everyone. It does not test a treatment, so direct patient benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC CARDIOMYOPATHIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AP-HP La Salpêtrière
RECRUITINGParis, 75013, France
-
CHU Angers
RECRUITINGAngers, 49000, France
-
CHU Brest
RECRUITINGBrest, 29000, France
-
CHU de Nantes
RECRUITINGNantes, 44093, France
-
CHU de Rennes
RECRUITINGRennes, 35000, France